Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chiara

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Gynaecological Oncology|January 1, 1992
Cisplatin-based combination chemotherapy with or without doxorubicin in advanced epithelial ovarian cancer: 8-year update of a randomized multicentric clinical trial. The Gruppo Oncologico Nord Ovest (GONO)A Gadducci, I Brunetti, M Bruzzone, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimensS Chiara, E Campora, L Merlini, et al.
Cancer Chemotherapy and Pharmacology|September 23, 1998
Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapyS Chiara, M T Nobile, M Vincenti, et al.
Gynecologic Oncology|April 1, 1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancerE Campora, M Bruzzone, S Chiara, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|June 1, 1990
Effect of recombinant human TNF on human ovarian cancer cell linesA Vigani, L Miglietta, S Chiara, et al.
Anticancer Research|September 1, 1992
Clinical stage I and II endometrial carcinoma: multivariate analysis of prognostic factorsS Mammoliti, M Bruzzone, S Chiara, et al.
Cancer|September 15, 1989
Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survivalP F Conte, A Alama, A Rubagotti, et al.
Critical Reviews in Oncology/Hematology|February 13, 2001
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapyS Chiara, R Lionetto, M Vincenti, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Second instance chemotherapy with high-dose cisplatin in patients with advanced ovarian neoplasms in progression or recurrence after treatment with cisplatin]M Bruzzone, P F Conte, S Chiara, et al.
American Journal of Clinical Oncology|August 1, 1994
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)S Chiara, M Bruzzone, L Merlini, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Gynaecological Oncology|January 1, 1992
Cisplatin-based combination chemotherapy with or without doxorubicin in advanced epithelial ovarian cancer: 8-year update of a randomized multicentric clinical trial. The Gruppo Oncologico Nord Ovest (GONO)A Gadducci, I Brunetti, M Bruzzone, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recurrent ovarian carcinoma: salvage treatment with platinum in patients responding to first-line platinum-based regimensS Chiara, E Campora, L Merlini, et al.
Cancer Chemotherapy and Pharmacology|September 23, 1998
Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapyS Chiara, M T Nobile, M Vincenti, et al.
Gynecologic Oncology|April 1, 1990
Intraperitoneal cytosine arabinoside administered in sequence with systemic cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancerE Campora, M Bruzzone, S Chiara, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|June 1, 1990
Effect of recombinant human TNF on human ovarian cancer cell linesA Vigani, L Miglietta, S Chiara, et al.
Anticancer Research|September 1, 1992
Clinical stage I and II endometrial carcinoma: multivariate analysis of prognostic factorsS Mammoliti, M Bruzzone, S Chiara, et al.
Cancer|September 15, 1989
Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survivalP F Conte, A Alama, A Rubagotti, et al.
Critical Reviews in Oncology/Hematology|February 13, 2001
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapyS Chiara, R Lionetto, M Vincenti, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Second instance chemotherapy with high-dose cisplatin in patients with advanced ovarian neoplasms in progression or recurrence after treatment with cisplatin]M Bruzzone, P F Conte, S Chiara, et al.
American Journal of Clinical Oncology|August 1, 1994
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)S Chiara, M Bruzzone, L Merlini, et al.
Pageof 7